Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?

02.10.25 18:10 Uhr

Werte in diesem Artikel
Aktien

247,80 EUR 3,55 EUR 1,45%

Indizes

6.715,4 PKT 4,2 PKT 0,06%

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Cigna (CI), which belongs to the Zacks Medical - HMOs industry.This health insurer has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 3.16%.For the last reported quarter, Cigna came out with earnings of $7.2 per share versus the Zacks Consensus Estimate of $7.14 per share, representing a surprise of 0.84%. For the previous quarter, the company was expected to post earnings of $6.39 per share and it actually produced earnings of $6.74 per share, delivering a surprise of 5.48%.Price and EPS SurpriseFor Cigna, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank.Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.Cigna has an Earnings ESP of +0.43% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #3 (Hold), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on October 30, 2025.Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric. Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.Free Report: Profiting from the 2nd Wave of AI ExplosionThe next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.Investors who bought shares like Nvidia at the right time have had a shot at huge gains.But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.Access AI Boom 2.0 now, absolutely free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cigna Group (CI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: The Cigna Group Registered und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf The Cigna Group Registered

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf The Cigna Group Registered

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu The Cigna Group Registered Shs

Wer­bung

Analysen zu The Cigna Group Registered Shs

DatumRatingAnalyst
20.07.2018Express Scripts NeutralRobert W. Baird & Co. Incorporated
08.03.2018Express Scripts Equal WeightBarclays Capital
08.03.2018Cigna OverweightBarclays Capital
31.01.2018Express Scripts OutperformRBC Capital Markets
15.12.2017Express Scripts OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
08.03.2018Cigna OverweightBarclays Capital
31.01.2018Express Scripts OutperformRBC Capital Markets
15.12.2017Express Scripts OutperformRobert W. Baird & Co. Incorporated
14.12.2017Express Scripts BuyMaxim Group
04.12.2017Express Scripts BuyDeutsche Bank AG
DatumRatingAnalyst
20.07.2018Express Scripts NeutralRobert W. Baird & Co. Incorporated
08.03.2018Express Scripts Equal WeightBarclays Capital
19.09.2017Express Scripts Sector PerformRBC Capital Markets
21.07.2017Express Scripts HoldNeedham & Company, LLC
26.04.2017Express Scripts HoldEdward Jones
DatumRatingAnalyst
22.02.2016Express Scripts SellDeutsche Bank AG
13.01.2009CIGNA sellCitigroup Corp.
07.11.2007CIGNA underweightLehman Brothers Inc.
02.11.2006Update CIGNA Corp.: UnderweightLehman Brothers

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Cigna Group Registered Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen